Manufacturing
At Relic Biotech we believe medicine is not for profit, but for people. Each medicine delivered by relic biotech is best in quality and purity. We manufacture our products as per Current Good Manufacturing Practise (cGMP). All our products are manufactured in highest degree of automation, optimal machine operation, shortest changeover times, minimum possible product loss, Scalable output and End-to-end process excellence. Our team of experts ensure products and system designs to delivered medicine which are shelf life stable, cross contamination free and meet global standard.
Before a strategic alliance with any manufacturing facility for active pharmaceutical ingredient or excipient our technical team of experts perform following screening in three phases.
- Manufacturing facility screening. (WHO-GMP, US-FDA Approval, DMF filing)
- Technology screening. (screening for best technology which deliver quality & cost)
- Manufacturing process screening. (IP, BP, USP)
- QC technology and process screening (IP, BP, USP)
- QA screening (cGMPs Compliance)
- Test for Shelf-life Stability. Test for accelerated Stability.
- Test for cross contamination. Test for Medicine contain.
- API Screening (QC, DMF, CTD, Tech. Pac)
- Excipient Screening (QC, DMF, CTD, Tech. Pac)